Skip to content

Glycemic and Satiety Response to Fiber and Glycemic Index of Meals in Diabetes

Glycemic and Satiety Response to Meals With Different Fiber Content and Glycemic Index in Type 2 Diabetic Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01410292
Enrollment
20
Registered
2011-08-05
Start date
2011-03-31
Completion date
2012-01-31
Last updated
2011-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

Keywords

fiber, glycemic index, glycemic response, diabetes, ghrelin

Brief summary

The aim of this study is to assess the post-prandial response of four breakfast with different content of dietary fiber and glycemic index on glycemic response and satiety in patients with type 2 diabetes.

Detailed description

Design study: Single-blind crossover randomized clinical trial Hypothesis: A meal with high GI and high fiber content determines a lower glycemic response compared to a meal with high GI and low fiber content (fiber beneficial effect on glycemic response independent of glycemic index. Test meals: Four test meals isocaloric and with the same proportion of macronutrients will be evaluated (5 kcal/kg, 17% of energy provided by protein, 58% of energy provided by carbohydrates, and 25% of energy provided by fat): Test Meal A:high glycemic index (GI= 60.3%) and high fiber content(5.88g) Test Meal B:high glycemic index (GI= 62.8%) and LOW fiber content(2.05g) Test Meal C:low glycemic index (GI= 37.0%) and high fiber content(5.75g) Test Meal D:low glycemic index (GI= 38.4%) and high fiber content(1.91g) Outcomes: Glycemic response: serum glucose and insulin Satiety response: serum ghrelin and subjective assessment of satiety by a specific scale for measurement of appetite in single test meal studies. Logistic: Patients will undergo a clinical, nutritional and laboratory evaluation for confirm the inclusion criteria and will be request to give their written informed consent. All participants will test each meal with a mean of seven days separating the individual test days.A 12h fast will precede all the study visits.Pre-and postprandial blood samples will be draw to determine the concentrations of serum insulin and plasma glucose, and ghrelin through an antecubital cannula before and 15, 30, 45, 60, 90, 120 and 180 min after the test meals. The VAS scale will be applied in these times.

Interventions

OTHERGI and fiber meals

meals with different fiber content and glycemic index

OTHERmeals

four different meal regarding GI and fiber content

Sponsors

Federal University of Rio Grande do Sul
CollaboratorOTHER
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
CollaboratorOTHER_GOV
Hospital de Clinicas de Porto Alegre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* type 2 diabetes, * HbA1c \< 9%, * BMI \< 35kg/m², * Metformin and/or diet as treatment for diabetes

Exclusion criteria

* Use of insulin as diabetes treatment * digestive disease with malabsorption * diabetes neuropathy with gastroparesis

Design outcomes

Primary

MeasureTime frameDescription
glycemic controlfasting and post-prandial (differents times during 180 minutes)glucose and insulin

Secondary

MeasureTime frameDescription
measures of satiety and appetitefasting and post-prandial (different times for 180 min)ghrelin and subjective analogue scale of appetite

Countries

Brazil

Contacts

Primary ContactFlávia M Silva
flavia.moraes.silva@hotmail.com93771824

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 18, 2026